Mississippi Healthcare Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Mississippi Healthcare Reporter.

Press releases published on September 18, 2026

an hour ago

Medical Devices Market Size to Hit $817.78 Billion by 2031 – MarketsandMarkets™

Indeterminate GlobeNewswire

2 hours ago

Global Virus Network Statement on H5N1 Detections in Australian Mammals

Indeterminate GlobeNewswire

3 hours ago

Hydration Room Expands Beyond California Opening First Clinic in Texas

Indeterminate GlobeNewswire

3 hours ago

Aspen Neuroscience Announces Publication of Sasineprocel Preclinical Data in "Cell Stem Cell"

Indeterminate GlobeNewswire

3 hours ago

Alaunos Therapeutics, Inc. Announces Pricing of Registered Direct Offering priced at-the-market under Nasdaq rules

Indeterminate GlobeNewswire

3 hours ago

Silo Pharma Receives U.S. Patent Allowance for SPC-15 PTSD Treatment, Expanding Intellectual Property Portfolio

Indeterminate GlobeNewswire

3 hours ago

OneMedNet Reports Record Bookings as Faster Fulfillment Begins

Indeterminate GlobeNewswire

3 hours ago

TOMI Environmental Solutions Reports Accelerating Growth in SteraMist Service Revenue

Indeterminate GlobeNewswire

4 hours ago

XORTX Announces Planned FDA IND Submission for XRx-026 Gout Program Using XORLO™, Targeting USD$700M+ U.S. Gout Market Opportunity

Indeterminate GlobeNewswire

4 hours ago

Velocity Clinical Research appoints Justin Starzyk as Chief Executive Officer

Indeterminate GlobeNewswire

4 hours ago

Abeona Therapeutics® Congratulates Ultragenyx on U.S. FDA Approval of FAYUVI™ Gene Therapy for Sanfilippo Syndrome Type A (MPS IIIA)

Indeterminate GlobeNewswire

5 hours ago

Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

5 hours ago

BlossomHill Therapeutics Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

5 hours ago

BioStem Technologies Secures Up to $40 Million in a Committed Equity Facility

Indeterminate GlobeNewswire

5 hours ago

CDT Partners with QIMA Life Sciences to Evaluate Novel Tapinarof Combinations in Psoriasis and Vitiligo

Indeterminate GlobeNewswire

6 hours ago

Zealand Pharma receives positive CHMP opinion for Zeydovio™ (glepaglutide) for the treatment of short bowel syndrome

Indeterminate GlobeNewswire

6 hours ago

The Ensign Group, Inc. Declares Quarterly Dividend of $0.0650 Per Share

Indeterminate GlobeNewswire

8 hours ago

Ipsen appoints Mariette Finet to its Board of Directors

Indeterminate GlobeNewswire

8 hours ago

Ipsen nomme Mariette Finet administratrice au sein de son Conseil d’administration  

Indeterminate GlobeNewswire

15 hours ago

Immumax Expands Global Access to the E-Tapper to Empower Natural Health Management from Home

Indeterminate GlobeNewswire